DK0820284T3 - Biologisk aktive ureido-derivater, der kan anvendes ved behandlingen af multipen sklerose - Google Patents

Biologisk aktive ureido-derivater, der kan anvendes ved behandlingen af multipen sklerose

Info

Publication number
DK0820284T3
DK0820284T3 DK97904356T DK97904356T DK0820284T3 DK 0820284 T3 DK0820284 T3 DK 0820284T3 DK 97904356 T DK97904356 T DK 97904356T DK 97904356 T DK97904356 T DK 97904356T DK 0820284 T3 DK0820284 T3 DK 0820284T3
Authority
DK
Denmark
Prior art keywords
treatment
biologically active
multiple sclerosis
derivatives useful
ureido derivatives
Prior art date
Application number
DK97904356T
Other languages
English (en)
Inventor
Nicola Mongelli
Andrea Lombardi Borgia
Rachele Alzani
Elena Cozzi
Massimo Temponi
Francesco Colotta
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Application granted granted Critical
Publication of DK0820284T3 publication Critical patent/DK0820284T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK97904356T 1996-02-09 1997-01-24 Biologisk aktive ureido-derivater, der kan anvendes ved behandlingen af multipen sklerose DK0820284T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9602721.4A GB9602721D0 (en) 1996-02-09 1996-02-09 Biologically active ureido derivatives useful in the treatment of multiple sclerosis
PCT/EP1997/000412 WO1997028796A1 (en) 1996-02-09 1997-01-24 Biologically active ureido derivatives useful in the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
DK0820284T3 true DK0820284T3 (da) 2000-07-24

Family

ID=10788461

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97904356T DK0820284T3 (da) 1996-02-09 1997-01-24 Biologisk aktive ureido-derivater, der kan anvendes ved behandlingen af multipen sklerose

Country Status (22)

Country Link
US (1) US5859046A (da)
EP (1) EP0820284B1 (da)
JP (1) JPH11504041A (da)
KR (1) KR19980703718A (da)
AR (1) AR005724A1 (da)
AT (1) ATE189388T1 (da)
AU (1) AU1720097A (da)
BR (1) BR9702075A (da)
CA (1) CA2217008A1 (da)
DE (1) DE69701243T2 (da)
DK (1) DK0820284T3 (da)
EA (1) EA000166B1 (da)
ES (1) ES2144844T3 (da)
GB (1) GB9602721D0 (da)
GR (1) GR3033332T3 (da)
HU (1) HUP9900796A2 (da)
IL (1) IL121808A0 (da)
NO (1) NO974651L (da)
PL (1) PL322717A1 (da)
PT (1) PT820284E (da)
WO (1) WO1997028796A1 (da)
ZA (1) ZA97902B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1711499A (en) 1997-12-04 1999-06-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds or inhibition of inflammation
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
US6348464B1 (en) 1999-11-12 2002-02-19 Guilford Pharmaceuticals, Inc. Pyrrolecarbonylimino derivatives as naaladase inhibitors
EP1988088A1 (en) 2003-03-03 2008-11-05 Guilford Pharmaceuticals Inc. Thiolactones
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
GB9307948D0 (en) * 1993-04-16 1993-06-02 Erba Carlo Spa Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Also Published As

Publication number Publication date
AR005724A1 (es) 1999-07-14
CA2217008A1 (en) 1997-08-14
ZA97902B (en) 1997-08-01
AU1720097A (en) 1997-08-28
ATE189388T1 (de) 2000-02-15
GB9602721D0 (en) 1996-04-10
HUP9900796A2 (hu) 1999-07-28
PT820284E (pt) 2000-07-31
NO974651D0 (no) 1997-10-08
MX9707673A (es) 1997-11-29
DE69701243T2 (de) 2000-09-07
NO974651L (no) 1997-12-02
ES2144844T3 (es) 2000-06-16
DE69701243D1 (de) 2000-03-09
PL322717A1 (en) 1998-02-16
BR9702075A (pt) 1998-06-09
EP0820284B1 (en) 2000-02-02
KR19980703718A (ko) 1998-12-05
EA199700302A1 (ru) 1998-04-30
GR3033332T3 (en) 2000-09-29
WO1997028796A1 (en) 1997-08-14
US5859046A (en) 1999-01-12
JPH11504041A (ja) 1999-04-06
IL121808A0 (en) 1998-02-22
EA000166B1 (ru) 1998-10-29
EP0820284A1 (en) 1998-01-28

Similar Documents

Publication Publication Date Title
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
DK0914103T3 (da) Behandling af hæmoglobinopati
DE69528512D1 (de) Aktiver akustischer Überzug
DE69725373D1 (de) Aktives Implantat
FI972087A (fi) Dihydropyrimidiineja ja niiden käyttöjä
DE69718818D1 (de) Herstellung von kanälen in metallkörpern
DE69715482T2 (de) Herstellung von 1,1,1,3,3-Pentachlorbutan und von 1,1,1,3,3-Pentafluorbutan
DE69720111T2 (de) Vorläufer von Duftstoffen
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
DK1017408T3 (da) Anvendelse af tetrahydrolipstatin i behandling af diabetes type II
DK0907358T3 (da) Behandling med ensartet afgivelse af lægemiddel
ID16154A (id) Komposisi monomer yang distabilisasi
DK0932400T3 (da) Antikonvulsive derivater, der er nyttige ved behandling af neuropatisk smerte
DK0820284T3 (da) Biologisk aktive ureido-derivater, der kan anvendes ved behandlingen af multipen sklerose
DE69619565T2 (de) Bioverträglichkeit harter flächen
FI980543A0 (fi) Spetsdragningsanordning och foerfarande foer spetsdragning av en bana
NO962503D0 (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
DK0944603T3 (da) Fremgangsmåde til fremstilling af 2-amino-2-imidazolin-, guanidin- og 2-amino-3,4,5,6-tetrahydropyrimidin-derivater
DE69707562D1 (de) Aktives Filter
FR2722198B1 (fr) 1derives de silylmethyl-anilines, le2fabrication, et leur utilisation co
DE9310356U1 (de) Spreizduebel
DE59803609D1 (de) Behandlung von Kunststoffoberflächen
FI970269A (fi) 1,3-diolipohjaisten esterien seokset, menetelmä 1,3-diolipohjaisten esterien valmistamiseksi sekä esterien käyttö
FR2757360B1 (fr) Dispositif modulaire d'agencement, notamment du type gondole
FR2718335B1 (fr) Elément de support notamment d'étagères.